Bank of New York Mellon’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.69M Sell
192,524
-5,653
-3% -$79K ﹤0.01% 2596
2025
Q1
$2.67M Buy
198,177
+1,655
+0.8% +$22.3K ﹤0.01% 2537
2024
Q4
$3.77M Buy
196,522
+25,692
+15% +$493K ﹤0.01% 2428
2024
Q3
$3.89M Sell
170,830
-37,846
-18% -$861K ﹤0.01% 2414
2024
Q2
$2.71M Buy
208,676
+56,814
+37% +$739K ﹤0.01% 2627
2024
Q1
$2.66M Buy
151,862
+2,051
+1% +$35.9K ﹤0.01% 2622
2023
Q4
$3.26M Buy
149,811
+11,634
+8% +$253K ﹤0.01% 2582
2023
Q3
$2.12M Sell
138,177
-3,875
-3% -$59.4K ﹤0.01% 2773
2023
Q2
$3.38M Buy
142,052
+2,417
+2% +$57.5K ﹤0.01% 2544
2023
Q1
$3.55M Sell
139,635
-12,918
-8% -$329K ﹤0.01% 2486
2022
Q4
$4.46M Buy
152,553
+62,290
+69% +$1.82M ﹤0.01% 2402
2022
Q3
$1.85M Buy
90,263
+20,983
+30% +$430K ﹤0.01% 2908
2022
Q2
$802K Buy
+69,280
New +$802K ﹤0.01% 3317
2019
Q4
Sell
-1,349
Closed -$15K 4228
2019
Q3
$15K Sell
1,349
-752
-36% -$8.36K ﹤0.01% 4188
2019
Q2
$65K Sell
2,101
-4,805
-70% -$149K ﹤0.01% 4087
2019
Q1
$289K Buy
6,906
+250
+4% +$10.5K ﹤0.01% 3749
2018
Q4
$302K Buy
6,656
+2,473
+59% +$112K ﹤0.01% 3703
2018
Q3
$350K Buy
4,183
+189
+5% +$15.8K ﹤0.01% 3773
2018
Q2
$384K Buy
3,994
+1,638
+70% +$157K ﹤0.01% 3744
2018
Q1
$248K Sell
2,356
-696
-23% -$73.3K ﹤0.01% 3847
2017
Q4
$478K Buy
3,052
+1,225
+67% +$192K ﹤0.01% 3626
2017
Q3
$250K Sell
1,827
-5
-0.3% -$684 ﹤0.01% 3816
2017
Q2
$355K Buy
+1,832
New +$355K ﹤0.01% 3746